Jessica Tassan
Stock Analyst at Piper Sandler
(0.90)
# 3,990
Out of 5,134 analysts
83
Total ratings
25.71%
Success rate
-16.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Reiterates: Overweight | $63 → $49 | $37.37 | +31.12% | 5 | Feb 6, 2026 | |
| DOCS Doximity | Maintains: Overweight | $70 → $40 | $24.58 | +62.73% | 5 | Feb 6, 2026 | |
| HNGE Hinge Health | Maintains: Overweight | $71 → $60 | $39.19 | +53.10% | 3 | Jan 9, 2026 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $30 | $20.59 | +45.70% | 6 | Jan 6, 2026 | |
| CVS CVS Health | Reiterates: Overweight | $99 → $101 | $78.20 | +29.16% | 6 | Dec 10, 2025 | |
| OSCR Oscar Health | Upgrades: Overweight | $13 → $25 | $13.39 | +86.71% | 7 | Nov 26, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $289.09 | +44.25% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $11.83 | +187.40% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $2.72 | +561.76% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $1.73 | +131.21% | 12 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $44 → $86 | $23.10 | +272.29% | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $288 → $272 | $184.99 | +47.03% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 → $8 | $5.53 | +44.67% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $290.71 | +28.65% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $4.56 | +163.16% | 6 | Feb 27, 2025 |
Omnicell
Feb 6, 2026
Reiterates: Overweight
Price Target: $63 → $49
Current: $37.37
Upside: +31.12%
Doximity
Feb 6, 2026
Maintains: Overweight
Price Target: $70 → $40
Current: $24.58
Upside: +62.73%
Hinge Health
Jan 9, 2026
Maintains: Overweight
Price Target: $71 → $60
Current: $39.19
Upside: +53.10%
Alignment Healthcare
Jan 6, 2026
Maintains: Overweight
Price Target: $20 → $30
Current: $20.59
Upside: +45.70%
CVS Health
Dec 10, 2025
Reiterates: Overweight
Price Target: $99 → $101
Current: $78.20
Upside: +29.16%
Oscar Health
Nov 26, 2025
Upgrades: Overweight
Price Target: $13 → $25
Current: $13.39
Upside: +86.71%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $289.09
Upside: +44.25%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $11.83
Upside: +187.40%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $2.72
Upside: +561.76%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $1.73
Upside: +131.21%
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $23.10
Upside: +272.29%
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $184.99
Upside: +47.03%
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $5.53
Upside: +44.67%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $290.71
Upside: +28.65%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $4.56
Upside: +163.16%